Compare Revvity Inc (RVTY) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Tilray Brands Inc — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: Revvity Inc is far larger — about 22.6× Tilray Brands Inc's market cap, and Revvity Inc pays a 0.26% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| RVTY | TLRY | |
|---|---|---|
Market Cap | $11.87B | $524.07M |
Sector | Technology | Health |
52-Week High | $117.75 | $21.00 |
52-Week Low | $82.26 | $4.23 |
Enterprise Value | $14.36B | $621.22M |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
